138 related articles for article (PubMed ID: 10575734)
21. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
[TBL] [Abstract][Full Text] [Related]
22. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists.
Peri R; Padmanabhan S; Rutledge A; Singh S; Triggle DJ
J Med Chem; 2000 Jul; 43(15):2906-14. PubMed ID: 10956198
[TBL] [Abstract][Full Text] [Related]
23. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and smooth muscle calcium channel antagonist effects of alkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-5-[2-(4,5-dihydro- 4,4-dimethyloxazolin-2-yl)]-3-pyridinecarboxylates.
Anana RD; Knaus EE
Arch Pharm (Weinheim); 1996; 329(8-9):408-12. PubMed ID: 8915102
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
[TBL] [Abstract][Full Text] [Related]
27. Long-acting dihydropyridine calcium antagonists. 6. Structure-activity relationships around 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy)methyl]-5 -(methoxycarbonyl)-6-methyl-1,4-dihydropyridine.
Alker D; Campbell SF; Cross PE
J Med Chem; 1991 Jan; 34(1):19-24. PubMed ID: 1992115
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
Inglesi M; Nicola M; Magnetti S
Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and characterization of a novel series of 1,4-dihydropyridine analogues for larvicidal activity against Anopheles arabiensis.
Dharma Rao BD; Bhandary S; Chopra D; Venugopala KN; Gleiser RM; Kasumbwe K; Odhav B
Chem Biol Drug Des; 2017 Sep; 90(3):397-405. PubMed ID: 28135765
[TBL] [Abstract][Full Text] [Related]
31. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
Shan R; Velazquez C; Knaus EE
J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
[TBL] [Abstract][Full Text] [Related]
32. [Calcium modulators of the anellated dihydropyridine type. Synthesis and pharmacologic action].
Rose U
Arzneimittelforschung; 1989 Nov; 39(11):1393-8. PubMed ID: 2619769
[TBL] [Abstract][Full Text] [Related]
33. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
Soldatov NM
Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
[TBL] [Abstract][Full Text] [Related]
35. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
[TBL] [Abstract][Full Text] [Related]
36. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.
Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A
Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
38. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
39. Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor.
Langs DA; Kwon YW; Strong PD; Triggle DJ
J Comput Aided Mol Des; 1991 Apr; 5(2):95-106. PubMed ID: 1651370
[TBL] [Abstract][Full Text] [Related]
40. Synthetic Diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylates Induce Apoptosis.
Ahn S; Lee Y; Park J; Lee J; Shin SY; Lee YH; Koh D; Lim Y
Med Chem; 2018; 14(8):851-862. PubMed ID: 29669502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
